BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

15262AT-1501-K207Open (affiliates only)BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney TransplantationNCT05983770IndustrialAdultTreatmentIIGlobalOtherPotter, StevenGeorgetown University Medical Center : Hillary McLean; Lombardi Comprehensive Cancer Center : Hillary McLeanGUMC Transplant; GUMC Transplant - Kidney16593Hillary McLeanHillary McLeanhm926@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>